{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:48:34Z","timestamp":1787021314192,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T00:00:00Z","timestamp":1418342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1245\/s10434-014-4267-4","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T11:43:35Z","timestamp":1418298215000},"page":"2401-2407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Histological and Molecular Subclassification of Pancreatic and Nonpancreatic Periampullary Cancers: Implications for (Neo) Adjuvant Systemic Treatment"],"prefix":"10.1245","volume":"22","author":[{"given":"J. I.","family":"Erdmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. A. L. M.","family":"Eskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. F. M.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Groot Koerkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Biermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. H. J.","family":"van Eijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"4267_CR1","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/bjs.1800821233","volume":"82","author":"J Klempnauer","year":"1995","unstructured":"Klempnauer J, Ridder GJ, Pichlmayr R. Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head. Br J Surg. 1995;82:1686\u20131691.","journal-title":"Br J Surg."},{"key":"4267_CR2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000100917","volume":"24","author":"HG Smeenk","year":"2007","unstructured":"Smeenk HG, Erdmann J, van Dekken H, et al. Long-term survival after radical resection for pancreatic head and ampullary cancer: a potential role for the EGF-R. Dig Surg. 2007;24:38\u201345.","journal-title":"Dig Surg."},{"key":"4267_CR3","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.amjsurg.2007.05.014","volume":"194","author":"J Erdmann","year":"2007","unstructured":"Erdmann J, van Eijck CHJ, Jeekel J. Standard resection of pancreatic cancer and the chance for cure. Am J Surg. 2007;194:S104\u20139S109.","journal-title":"Am J Surg."},{"key":"4267_CR4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jso.21374","volume":"100","author":"J Albores-Saavedra","year":"2009","unstructured":"Albores-Saavedra J, Schwartz AM, Batich K, Henson DE. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol. 2009;100:598\u2013605.","journal-title":"J Surg Oncol."},{"key":"4267_CR5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/SLA.0b013e318156eef3","volume":"246","author":"HG Smeenk","year":"2007","unstructured":"Smeenk HG, van Eijck CH, Hop WC, et al. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Ann Surg. 2007;246:734\u2013740.","journal-title":"Ann Surg."},{"key":"4267_CR6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00000658-199709000-00004","volume":"226","author":"CJ Yeo","year":"1997","unstructured":"Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226:248\u201357; discussion 257\u2013260.","journal-title":"Ann Surg."},{"key":"4267_CR7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11605-009-1080-7","volume":"14","author":"JM Winter","year":"2010","unstructured":"Winter JM, Cameron JL, Olino K, et al. Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg. 2010;14:379\u2013387.","journal-title":"J Gastrointest Surg."},{"key":"4267_CR8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/SLA.0b013e318190c53e","volume":"248","author":"MJ Morak","year":"2008","unstructured":"Morak MJ, van der Gaast A, Incrocci L, et al. Adjuvant intraarterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial. Ann Surg. 2008;248:1031\u20131041.","journal-title":"Ann Surg."},{"key":"4267_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2012.7352","volume":"308","author":"JP Neoptolemos","year":"2012","unstructured":"Neoptolemos JP, Moore MJ, Cox TF, et al. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA. 2012;308:147\u2013156.","journal-title":"JAMA"},{"key":"4267_CR10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0039-6109(05)70142-0","volume":"81","author":"JM Sarmiento","year":"2001","unstructured":"Sarmiento JM, Nagomey DM, Sarr MG, Farnell MB. Periampullary cancers: are there differences? Surg Clin North Am. 2001;81:543\u2013555.","journal-title":"Surg Clin North Am"},{"key":"4267_CR11","unstructured":"Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC;\u00a02010."},{"key":"4267_CR12","unstructured":"Feakins R VC, Campbell F. Survey of UK Pathologists\u2019 Approach to Pancreatectomies for Ampullary\/Pancreatic\/Bile Duct Cancer. http:\/\/www.bsg.org.uk\/sections\/pathology-articles\/index.html . Accessed 10 Sep 2013."},{"key":"4267_CR13","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/bjs.8734","volume":"99","author":"CS Verbeke","year":"2012","unstructured":"Verbeke CS, Gladhaug IP. Resection margin involvement and tumour origin in pancreatic head cancer. Br J Surg. 2012;99:1036\u20131049.","journal-title":"Br J Surg"},{"key":"4267_CR14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ejso.2012.07.113","volume":"38","author":"E Pomianowska","year":"2012","unstructured":"Pomianowska E, Grzyb K, Westgaard A, Clausen OP, Gladhaug IP. Reclassification of tumour origin in resected periampullary adenocarcinomas reveals underestimation of distal bile duct cancer. Eur J Surg Oncol. 2012;38:1043\u20131050.","journal-title":"Eur J Surg Oncol"},{"key":"4267_CR15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/gut.2004.047191","volume":"54","author":"M Carpelan-Holmstrom","year":"2005","unstructured":"Carpelan-Holmstrom M, Nordling S, Pukkala E, et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study reevaluating the data of the Finnish Cancer Registry. Gut. 2005;54:385\u2013387.","journal-title":"Gut."},{"key":"4267_CR16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1245\/s10434-012-2603-0","volume":"20","author":"A Westgaard","year":"2013","unstructured":"Westgaard A, Pomianowska E, Clausen OP, Gladhaug IP. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies? Ann Surg Oncol. 2013;20:430\u2013439.","journal-title":"Ann Surg Oncol."},{"key":"4267_CR17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00000478-200407000-00005","volume":"28","author":"H Zhou","year":"2004","unstructured":"Zhou H, Schaefer N, Wolff M, Fischer HP. Carcinoma of the ampulla of Vater: comparative histologic\/immunohistochemical classification and follow-up. Am J Surg Pathol. 2004;28:875\u2013882.","journal-title":"Am J Surg Pathol"},{"key":"4267_CR18","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.2012.46.8868","volume":"31","author":"DK Chang","year":"2013","unstructured":"Chang DK, Jamieson NB, Johns AL, et al. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. J Clin Oncol. 2013;31:1348\u20131356.","journal-title":"J Clin Oncol."},{"key":"4267_CR19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","volume":"358","author":"F Ciardiello","year":"2008","unstructured":"Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med. 2008;358:1160\u20131174.","journal-title":"N Engl J Med."},{"key":"4267_CR20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00000658-199912000-00005","volume":"230","author":"H Friess","year":"1999","unstructured":"Friess H, Wang L, Zhu Z, et al. Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas. Ann Surg. 1999;230:767\u2013774; discussion 774\u2013765.","journal-title":"Ann Surg."},{"key":"4267_CR21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3748\/wjg.v12.i3.437","volume":"12","author":"KL Prenzel","year":"2006","unstructured":"Prenzel KL, Warnecke-Eberz U, Brabender J, et al. Differential c-erbB-1 and c-erbB-2 mRNA expression in cancer of the pancreas compared with cancer of the papilla of Vater. World J Gastroenterol. 2006;12:437\u2013442.","journal-title":"World J Gastroenterol"},{"key":"4267_CR22","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1038\/onc.2010.87","volume":"29","author":"S Bafna","year":"2010","unstructured":"Bafna S, Kaur S, Batra SK. Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene. 2010;29:2893\u2013904.","journal-title":"Oncogene."},{"key":"4267_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0070-2153(06)78001-2","volume":"78","author":"KL Carraway III","year":"2007","unstructured":"Carraway KL III, Funes M, Workman HC, Sweeney C. Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways. Curr Top Dev Biol. 2007;78:1\u201322.","journal-title":"Curr Top Dev Biol."},{"key":"4267_CR24","first-page":"2240","volume":"46","author":"Y Masaki","year":"1999","unstructured":"Masaki Y, Oka M, Ogura Y, et al. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma. Hepatogastroenterology. 1999;46:2240\u20132245.","journal-title":"Hepatogastroenterology."},{"key":"4267_CR25","first-page":"4033","volume":"7","author":"M Andrianifahanana","year":"2001","unstructured":"Andrianifahanana M, Moniaux N, Schmied BM, et al. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res. 2001;7:4033\u20134040.","journal-title":"Clin Cancer Res."},{"key":"4267_CR26","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/00006676-200304000-00022","volume":"26","author":"HU Park","year":"2003","unstructured":"Park HU, Kim JW, Kim GE, et al. Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia. Pancreas. 2003;26:e48\u2013e54.","journal-title":"Pancreas."},{"key":"4267_CR27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1309\/7Y7N-M1WM-R0YK-M2VA","volume":"117","author":"MJ Swartz","year":"2002","unstructured":"Swartz MJ, Batra SK, Varshney GC, et al. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am J Clin Pathol. 2002;117:791\u2013796.","journal-title":"Am J Clin Pathol."},{"key":"4267_CR28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s005340200037","volume":"9","author":"S Yonezawa","year":"2002","unstructured":"Yonezawa S, Nakamura A, Horinouchi M, Sato E. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J Hepatobil Pancreat Surg. 2002;9:328\u2013341.","journal-title":"J Hepatobil Pancreat Surg."},{"key":"4267_CR29","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/sj.bjc.6604364","volume":"98","author":"WR Matull","year":"2008","unstructured":"Matull WR, Andreola F, Loh A, et al. MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. Br J Cancer. 2008;98:1675\u20131681.","journal-title":"Br J Cancer."},{"key":"4267_CR30","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/bjs.7107","volume":"97","author":"MM Aloysius","year":"2010","unstructured":"Aloysius MM, Zaitoun AM, Awad S, Ilyas M, Rowlands BJ, Lobo DN. Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer. Br J Surg. 2010;97:1269\u20131278.","journal-title":"Br J Surg."},{"key":"4267_CR31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2559.2009.03227.x","volume":"54","author":"A Westgaard","year":"2009","unstructured":"Westgaard A, Schjolberg AR, Cvancarova M, Eide TJ, Clausen OP, Gladhaug IP. Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours. Histopathology. 2009;54:337\u2013347.","journal-title":"Histopathology."},{"key":"4267_CR32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1746-1596-5-75","volume":"5","author":"Y Kawabata","year":"2010","unstructured":"Kawabata Y, Tanaka T, Nishisaka T, Inao T, Nishi T, Yano S. Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: correlation with tumor progression and prognosis. Diagn Pathol. 2010;5:75.","journal-title":"Diagn Pathol."},{"key":"4267_CR33","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1016\/j.ejca.2011.08.016","volume":"47","author":"JA Zee van der","year":"2011","unstructured":"van der Zee JA, van Eijck CH, Hop WC, et al. Angiogenesis: a prognostic determinant in pancreatic cancer? Eur J Cancer. 2011;47:2576\u20132584.","journal-title":"Eur J Cancer."},{"key":"4267_CR34","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1016\/j.ejca.2010.07.024","volume":"46","author":"JA Zee van der","year":"2010","unstructured":"van der Zee JA, ten Hagen TL, Hop WC, et al. Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer. Eur J Cancer. 2010;46:3393\u20133399.","journal-title":"Eur J Cancer."},{"key":"4267_CR35","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1101\/gad.1415606","volume":"20","author":"AF Hezel","year":"2006","unstructured":"Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006;20:1218\u20131249.","journal-title":"Genes Dev."},{"key":"4267_CR36","first-page":"129","volume":"3","author":"JR Howe","year":"1997","unstructured":"Howe JR, Klimstra DS, Cordon-Cardo C, Paty PB, Park PY, Brennan MF. K-ras mutation in adenomas and carcinomas of the ampulla of vater. Clin Cancer Res. 1997;3:129\u2013133.","journal-title":"Clin Cancer Res."},{"key":"4267_CR37","first-page":"867","volume":"14","author":"MC Chang","year":"2005","unstructured":"Chang MC, Chang YT, Tien YW, Sun CT, Wu MS, Lin JT. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization. Oncol Rep. 2005;14:867\u2013872.","journal-title":"Oncol Rep."},{"key":"4267_CR38","doi-asserted-by":"crossref","first-page":"e65144","DOI":"10.1371\/journal.pone.0065144","volume":"8","author":"MJ Overman","year":"2013","unstructured":"Overman MJ, Zhang J, Kopetz S, et al. Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome. PloS One. 2013;8:e65144.","journal-title":"PloS One."},{"key":"4267_CR39","doi-asserted-by":"crossref","unstructured":"Collins AL, Wojcik S, Liu J, et al. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. Ann Surg Oncol.\u00a02013;21:133\u2013138.","DOI":"10.1245\/s10434-013-3240-y"},{"key":"4267_CR40","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/modpathol.2012.122","volume":"25","author":"NA Schultz","year":"2012","unstructured":"Schultz NA, Werner J, Willenbrock H, et al. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. Mod Pathol. 2012;25:1609\u20131622.","journal-title":"Mod Pathol."},{"key":"4267_CR41","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archsurg.1985.01390320023003","volume":"120","author":"MH Kalser","year":"1985","unstructured":"Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 1985;120:899\u2013903.","journal-title":"Arch Surg."},{"key":"4267_CR42","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0959-8049(05)80349-1","volume":"29A","author":"KE Bakkevold","year":"1993","unstructured":"Bakkevold KE, Arnesjo B, Dahl O, Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater: results of a controlled, prospective, randomised multicentre study. Eur J Cancer. 1993;29A:698\u2013703.","journal-title":"Eur J Cancer."},{"key":"4267_CR43","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","volume":"230","author":"JH Klinkenbijl","year":"1999","unstructured":"Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg. 1999;230:776\u2013782; discussion 782\u2013774.","journal-title":"Ann Surg."},{"key":"4267_CR44","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(01)06651-X","volume":"358","author":"JP Neoptolemos","year":"2001","unstructured":"Neoptolemos JP, Dunn JA, Stocken DD, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet. 2001;358:1576\u201385.","journal-title":"Lancet."},{"key":"4267_CR45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","volume":"297","author":"H Oettle","year":"2007","unstructured":"Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297:267\u2013277.","journal-title":"JAMA."},{"key":"4267_CR46","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2013.279201","volume":"310","author":"H Oettle","year":"2013","unstructured":"Oettle H, Neuhaus P, Hochhaus A, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013;310:1473\u20131481.","journal-title":"JAMA."},{"key":"4267_CR47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jjco\/hyi234","volume":"36","author":"T Kosuge","year":"2006","unstructured":"Kosuge T, Kiuchi T, Mukai K, Kakizoe T. Japanese study group of adjuvant therapy for pancreatic C. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer. Jap J Clin Oncol. 2006;36:159\u2013165.","journal-title":"Jap J Clin Oncol."},{"key":"4267_CR48","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jama.299.9.1019","volume":"299","author":"WF Regine","year":"2008","unstructured":"Regine WF, Winter KA, Abrams RA, et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA. 2008;299:1019\u20131026.","journal-title":"JAMA."},{"key":"4267_CR49","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2010.1275","volume":"304","author":"JP Neoptolemos","year":"2010","unstructured":"Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA. 2010;304:1073\u20131081.","journal-title":"JAMA."},{"key":"4267_CR50","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273\u20131281.","journal-title":"N Engl J Med."},{"key":"4267_CR51","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjc.6605256","volume":"101","author":"H Ueno","year":"2009","unstructured":"Ueno H, Kosuge T, Matsuyama Y, et al. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer. Japanese study group of adjuvant therapy for pancreatic cancer. Br J Cancer. 2009;101:908\u2013915.","journal-title":"Br J Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4267-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-4267-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4267-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T07:24:36Z","timestamp":1559633076000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-4267-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,12]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["4267"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-4267-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,12]]}}}